GKWIM
IBB icon

Gerber Kawasaki Wealth & Investment Management’s iShares Biotechnology ETF IBB Stock Holding History

Gerber Kawasaki Wealth & Investment Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.75M Buy
10,386
+173
+2% +$29.6K 0.06% 124
2025
Q4 		$1.72M Sell
10,213
-399
-4% -$64.8K 0.06% 122
2025
Q3 		$1.53M Sell
10,612
-686
-6% -$93.6K 0.05% 129
2025
Q2 		$1.43M Sell
11,298
-9,191
-45% -$1.13M 0.06% 127
2025
Q1 		$2.62M Sell
20,489
-1,602
-7% -$217K 0.12% 94
2024
Q4 		$2.92M Sell
22,091
-581
-3% -$81.7K 0.13% 90
2024
Q3 		$3.3M Buy
22,672
+539
+2% +$78K 0.15% 84
2024
Q2 		$3.04M Sell
22,133
-250
-1% -$33.4K 0.15% 84
2024
Q1 		$3.07M Buy
22,383
+411
+2% +$56.1K 0.17% 82
2023
Q4 		$2.98M Sell
21,972
-2,225
-9% -$271K 0.18% 83
2023
Q3 		$2.96M Sell
24,197
-2,332
-9% -$297K 0.2% 82
2023
Q2 		$3.37M Sell
26,529
-889
-3% -$115K 0.23% 80
2023
Q1 		$3.54M Sell
27,418
-603
-2% -$78.9K 0.28% 68
2022
Q4 		$3.68M Sell
28,021
-3,039
-10% -$393K 0.33% 66
2022
Q3 		$3.63M Sell
31,060
-2,961
-9% -$368K 0.34% 59
2022
Q2 		$4M Sell
34,021
-11,398
-25% -$1.35M 0.38% 56
2022
Q1 		$5.92M Sell
45,419
-55,693
-55% -$7.25M 0.48% 39
2021
Q4 		$15.4M Buy
101,112
+100,470
+15,650% +$15.6M 1.23% 22
2021
Q3 		$642K Sell
642
-93,673
-99% -$15.8M 0.08% 90
2021
Q2 		$15.4M Buy
94,315
+878
+0.9% +$135K 1.58% 20
2021
Q1 		$14.1M Buy
93,437
+7,388
+9% +$1.17M 1.69% 19
2020
Q4 		$13M Buy
+86,049
New +$12.3M 1.81% 16
2020
Q3 		– Sell
-55,842
Closed -$7.63M – 135
2020
Q2 		$7.63M Buy
55,842
+13,039
+30% +$1.66M 1.69% 20
2020
Q1 		$4.61M Buy
42,803
+13,566
+46% +$1.56M 1.31% 27
2019
Q4 		$3.52M Sell
29,237
-5,883
-17% -$656K 0.89% 30
2019
Q3 		$3.49M Sell
35,120
-15,812
-31% -$1.66M 1% 27
2019
Q2 		$5.56M Sell
50,932
-15,427
-23% -$1.64M 1.62% 20
2019
Q1 		$7.42M Sell
66,359
-45,621
-41% -$5M 2.21% 14
2018
Q4 		$10.8M Sell
111,980
-5,758
-5% -$611K 3.8% 7
2018
Q3 		$14.3M Buy
117,738
+8,773
+8% +$1.03M 3.87% 8
2018
Q2 		$12.1M Buy
108,965
+6,487
+6% +$694K 3.61% 9
2018
Q1 		$10.9M Buy
102,478
+16,283
+19% +$1.8M 3.52% 8
2017
Q4 		$9.27M Buy
86,195
+18,905
+28% +$2.02M 3.2% 9
2017
Q3 		$7.61M Buy
67,290
+19,848
+42% +$2.12M 2.77% 13
2017
Q2 		$4.9M Sell
47,442
-1,191
-2% -$117K 1.86% 18
2017
Q1 		$4.66M Buy
48,633
+15,606
+47% +$1.49M 2% 17
2016
Q4 		$2.92M Buy
33,027
+21,621
+190% +$1.97M 1.54% 22
2016
Q3 		$1.1M Buy
+11,406
New +$1.09M 0.64% 38

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Gerber Kawasaki Wealth & Investment Management's IBB Position: Q1 2026 in Review

Gerber Kawasaki Wealth & Investment Management increased its iShares Biotechnology ETF (IBB) stake by 1.7% in Q1 2026, buying an estimated $29.6K and bringing the position to 10,386 shares worth $1.75M. The position accounts for 0.06% of the portfolio, ranked #124.

Gerber Kawasaki Wealth & Investment Management first reported a position in IBB in Q3 2016 and has held it in 38 quarters since. The position peaked at $15.4M in Q2 2021. 919 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Gerber Kawasaki Wealth & Investment Management held 10,386 shares of iShares Biotechnology ETF worth $1.75M as of Q1 2026.
  • Gerber Kawasaki Wealth & Investment Management bought 173 iShares Biotechnology ETF shares in Q1 2026, an estimated $29.6K.
  • iShares Biotechnology ETF made up 0.06% of Gerber Kawasaki Wealth & Investment Management's portfolio in Q1 2026, its #124 holding.
  • Gerber Kawasaki Wealth & Investment Management first reported a position in iShares Biotechnology ETF in Q3 2016 and has held it in 38 quarters since.
  • Gerber Kawasaki Wealth & Investment Management's iShares Biotechnology ETF position peaked at $15.4M in Q2 2021.
  • 919 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Gerber Kawasaki Wealth & Investment Management's 13F filing for Q1 2026, filed 7 May 2026.